Fundraising FoxEarlymarket — Full Portfolio
13 tracked investments · listed companies and verified rows first
Beeline makes compact GPS navigation devices (Moto II and Velo 2) and a companion app offering turn-by-turn directions, speed, and ride tracking for motorcyclists and cyclists.
ConsumerHardwareMobility & Transportation
Mark(Co-founder)Tom Putnam(Founder)in
Co-investorsTrue.Bain Capital
Cera is Europe's largest HealthTech company building AI tools and digital products to predict hospitalizations and improve care delivery for NHS and government partners.
AI & Machine LearningDigital HealthHealthtechCamden, GB
Dr. Ben Maruthappu(Founder)inBen Maruthappu(Founder)Mahiben Maruthappu(Founder)Marek Sacha(Founder)Martin Ocenas(Founder)
Co-investorsKairos HQKima VenturesLoric VenturesWalking VenturesYabeoCredo Ventures+3 more
Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Jerzy Kozyra(CEO)inMun Ching Lee(Cofounder)in
Co-investorsEntrepreneur FirstNorthstar Ventures
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
BiotechDigital HealthMedical Devices
Duleek Ranatunga(Founder)in
Co-investorsCompoundFly VenturesHoxton VenturesOctopus VenturesSoftBank Investment Advisers’ Emerge ProgramSOSV+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
British LithiumCyclist and motorcyclist navigationCyclist and motorcyclist navigation ventureHelicopter landing sites databaseIntegrated lithium mining ventureNanorobot disease detectionOrgan-on-a-chip cancer modellingOrgan-on-a-chip cancer modelling venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.